Literature DB >> 32181147

Right-sided obstructed hemivagina ipsilateral renal agenesis (OHVIRA): A case report.

Vaishnavi Malarazhagan1, Mayooran Veerasingham1, Kanapathippillai Sivanesan1.   

Abstract

INTRODUCTION: Obstructed hemivagina ipsilateral renal agenesis (OHVIRA) is a rare anomaly of the urogenital system. The characteristic triad of this syndrome, which was initially reported in 1950, is didelphys uterus, obstructed hemivagina, and ipsilateral renal agenesis (Embrey, 1950 [1]). CASE: A 17-year-old girl was referred with a 6-month history of offensive vaginal discharge. Magnetic resonance imaging (MRI) established the diagnosis of OHVIRA. She underwent surgery for drainage of the hematocolpos and excision of the vaginal septum followed by an uncomplicated recovery and the patient had normal menstrual cycles after surgery.
CONCLUSION: There should be a high suspicion of OHVIRA syndrome when encountering adolescent patients with non-specific abdominal or pelvic symptoms.
© 2020 The Authors.

Entities:  

Keywords:  Didelphys and bicollis; MRI, magnetic resonance imaging; Mullerian anomaly; OHVIRA; OHVIRA, Obstructed hemivagina ipsilateral renal agenesis; Obstructed hemivagina; Renal agenesis; USS, ultrasound scan; Urogenital malformation

Year:  2020        PMID: 32181147      PMCID: PMC7063130          DOI: 10.1016/j.crwh.2020.e00185

Source DB:  PubMed          Journal:  Case Rep Womens Health        ISSN: 2214-9112


Introduction

Obstructed hemivagina ipsilateral renal agenesis (OHVIRA) is a rare complex urogenital malformation. Clinical symptoms of this syndrome vary widely. OHVIRA should be considered as a differential diagnosis in young women and adolescents presenting with pelvic pain, tenderness, pelvic mass, persistent vaginal discharge, urinary symptoms and primary infertility. Strong suspicion and knowledge about this are important for accurate diagnosis. Clinical diagnosis is challenging and requires imaging studies; ultrasound scan (USS) and magnetic resonance imaging (MRI) play an essential role in diagnosis and treatment planning. Patients are usually diagnosed at puberty after menarche. Delayed diagnosis can lead to complications such as abscess formation, pelvic inflammatory disease, endometriosis, pyometra and infertility [2]. The differential diagnosis for unilateral kidney agenesis accompanied by non-specific abdominal symptoms in adolescent girls should include obstructive genital tract anomaly. Surgical removal of the vaginal septum (septostomy) is the main treatment method, outcomes of which are usually satisfactory. Expeditious surgical correction of the genital tract anomaly results in relief of symptoms.

Case Presentation

A 17-year-old female presented with a 6-month history of offensive vaginal discharge. She had achieved coitarche and used tampons with little concern. She did not have any significant medical or surgical history. She also denied dyspareunia, post-coital bleeding or urinary symptoms. Abdominal examination revealed mild lower abdominal tenderness without rebound or guarding. Vaginal examination demonstrated a bulge in the right upper vagina. USS findings were suspicious for right-sided renal agenesis and uterus didelphis. A subsequent MRI demonstrated the classical findings of right-sided OHVIRA. She had uterus didelphis (Fig. 1), bicolis and a right-sided obstructed hemivagina (Fig. 2). She underwent an examination under anesthetic (Fig. 3), hysteroscopy, incision and drainage of mucopyohaematoculpos and excision of vaginal septum (Fig. 4, Fig. 5). Intraoperative hysteroscopy confirmed uterus didelphis and bicolis. The septotomy was performed with a hand-held harmonic scalpel with minimal bleeding. There were no complications. She was discharged on day 1. Recovery was uncomplicated. At 6-week review, she had 1 normal menstrual cycle, no persistent abnormal vaginal discharge and normal coitus with no concerns.
Fig. 1

MRI coronal view demonstrating left (L) and right (R) uterine horns with left and right vagina.

Fig. 2

MRI transverse view demonstrating right obstructed hemivagina (R) with vaginal septum (S) and left vagina (L).

Fig. 3

Retractor (R) against vaginal septum (S) and left cervix (C) exposed. (For interpretation of the references to color in this figure, the reader is referred to the web version of this article.)

Fig. 4

After excision of septum with dilator in both cervix. (For interpretation of the references to color in this figure, the reader is referred to the web version of this article.)

Fig. 5

After entire septum excised and raw edges sutured. (For interpretation of the references to color in this figure, the reader is referred to the web version of this article.)

MRI coronal view demonstrating left (L) and right (R) uterine horns with left and right vagina. MRI transverse view demonstrating right obstructed hemivagina (R) with vaginal septum (S) and left vagina (L). Retractor (R) against vaginal septum (S) and left cervix (C) exposed. (For interpretation of the references to color in this figure, the reader is referred to the web version of this article.) After excision of septum with dilator in both cervix. (For interpretation of the references to color in this figure, the reader is referred to the web version of this article.) After entire septum excised and raw edges sutured. (For interpretation of the references to color in this figure, the reader is referred to the web version of this article.)

Discussion

Obstructed hemivagina ipsilateral renal agenesis (OHVIRA) is a rare form of Mullerian tract abnormality. The overall prevalence of Mullerian tract abnormality is 2% to 3% [3]. The incidence of OHVIRA syndrome is still unknown, with only few published case reports so far. Of note, Smith et al. reported 27 cases of OHVIRA and Candiani et al. reported long-term follow-up of 36 cases with double uterus, blind hemivagina and ipsilateral renal agenesis [4,5]. The characteristic triad of this syndrome is didelphys uterus, obstructed hemivagina, and ipsilateral renal agenesis [1]. The most common renal anomaly associated with this syndrome is renal agenesis, although other forms of renal malformations have been reported, including dysplastic kidney and renal duplication [5]. The pathogenesis of OHVIRA syndrome is thought to be multifactorial. It is related to an anomaly in development of paramesonephric (Mullerian) and mesonephric (Wolffian) ducts. The Wolffian ducts induce the normal development of Mullerian ducts and give origin to the kidneys. Abnormal development of the Wolffian ducts leads to the unilateral renal agenesis and imperforated hemivagina associated with OHVIRA syndrome [6]. Fusion failure of the Mullerian ducts leads to uterine didelphys and bicollis. Due to embryological development of the female urinary and reproductive symptoms, patients with renal malformations will benefit from evaluation of the reproductive structures and vice versa. The clinical presentation of Mullerian duct anomaly varies widely in symptoms and age at onset. A number of presentations have been reported, including pre-pubertal with urinary incontinence [7], adolescence with dysmenorrhea, difficulty with sexual intercourse or using a tampon, as well as delayed diagnosis in pregnancy due to cervical incompetence [8] and a rare case of a ruptured gravid uterus [9]. Early diagnosis is important to relieve symptoms and to avoid adverse effects. Timely treatment will prevent adverse obstetric outcomes such as miscarriage, preterm birth, malpresentation, fetal growth restriction and cesarean delivery [10,11]. Preconception counseling is important, as is antenatal care in a high-risk setting. Associated renal anomalies also confer an increased risk of hypertensive disease in pregnancy as well as long-term implications for chronic renal and cardiovascular disease [12]. Given the association with a variety of renal tract anomalies, including ectopic ureters, consideration should be given to pre-operative renal tract imaging to prevent the risk of iatrogenic urinary incontinence, should the ureter implant into the subsequently unobstructed vagina [13]. In addition, it may be time to address whether the term ‘agenesis’ should be changed to ‘anomaly’ due to the variety of renal tract anomalies associated with OHVIRA. First line of investigation for pelvic symptoms is usually an ultrasound scan, as it is easily available. However, MRI remains the imaging modality of choice to evaluate Mullerian duct abnormalities. MRI will accurately show the shape of uterine cavity, contour, cervical and vaginal abnormalities. Pre-operative imaging with MRI is essential to define the Mullerian duct structures and renal tract. It also assists with surgical planning [14]. Laparoscopy is still the gold standard for investigation of gynecological congenital abnormalities but is only used if MRI fails to establish a diagnosis or MRI is unavailable [15]. Treatment of OHVIRA is vaginoplasty. It is ideally a single surgery with drainage of the obstructed hemivagina and resection of the septum to restore normal vaginal function.

Conclusion

Gynecologists, pediatricians and radiologists should have high suspicion for OHVIRA syndrome when encountering adolescent patients with non-specific abdominal or pelvic symptoms. Knowledge of the syndrome is important for early diagnosis as well as an appropriate early treatment to avoid adverse effects.
  14 in total

1.  Herlyn-Werner-Wunderlich syndrome: a rare presentation with pyocolpos.

Authors:  Deven Cox; Brian H Ching
Journal:  J Radiol Case Rep       Date:  2012-03-01

2.  Double uterus, blind hemivagina, and ipsilateral renal agenesis: 36 cases and long-term follow-up.

Authors:  G B Candiani; L Fedele; M Candiani
Journal:  Obstet Gynecol       Date:  1997-07       Impact factor: 7.661

3.  OHVIRA with a twist: obstructed hemivagina ipsilateral renal anomaly with urogenital sinus in 2 patients.

Authors:  Irene Ma; Amy Williamson; Dorothy Rowe; Michael Ritchey; Kathleen Graziano
Journal:  J Pediatr Adolesc Gynecol       Date:  2013-09-26       Impact factor: 1.814

4.  Obstructed hemivagina and ipsilateral renal agenesis (OHVIRA) syndrome should be redefined as ipsilateral renal anomalies: cases of symptomatic atrophic and dysplastic kidney with ectopic ureter to obstructed hemivagina.

Authors:  Bruce Schlomer; Esequiel Rodriguez; Laurence Baskin
Journal:  J Pediatr Urol       Date:  2015-02-26       Impact factor: 1.830

5.  Management and outcome of patients with combined vaginal septum, bifid uterus, and ipsilateral renal agenesis (Herlyn-Werner-Wunderlich syndrome).

Authors:  Suad Gholoum; Pramod S Puligandla; Thomas Hui; Wendy Su; Elsa Quiros; Jean-Martin Laberge
Journal:  J Pediatr Surg       Date:  2006-05       Impact factor: 2.545

Review 6.  OHVIRA syndrome presenting with acute abdomen: a case report and review of the literature.

Authors:  Funda Gungor Ugurlucan; Ercan Bastu; Gokce Gulsen; Meryem Kurek Eken; Suleyman Engin Akhan
Journal:  Clin Imaging       Date:  2013-12-21       Impact factor: 1.605

7.  Severe Hemoperitoneum During Pregnancy with Obstructed Hemivagina and Ipsilateral Renal Anomaly Syndrome: A Case Report.

Authors:  Ayako Muraoka; Hiroyuki Tsuda; Tomomi Kotani; Fumitaka Kikkawa
Journal:  J Reprod Med       Date:  2016 May-Jun       Impact factor: 0.142

8.  Uterus didelphys associated with obstructed hemivagina and ipsilateral renal agenesis: MR findings in seven cases.

Authors:  Y O Tanaka; Y Kurosaki; T Kobayashi; N Eguchi; K Mori; Y Satoh; M Nishida; T Kubo; Y Itai
Journal:  Abdom Imaging       Date:  1998 Jul-Aug

Review 9.  Herlyn-Werner-Wunderlich syndrome: MRI findings, radiological guide (two cases and literature review), and differential diagnosis.

Authors:  Riccardo Del Vescovo; Sofia Battisti; Valerio Di Paola; Claudia L Piccolo; Roberto L Cazzato; Ilaria Sansoni; Rosario F Grasso; Bruno Beomonte Zobel
Journal:  BMC Med Imaging       Date:  2012-03-09       Impact factor: 1.930

10.  Spontaneous rupture of an unscarred gravid uterus in a primigravid woman at 32 weeks of gestation.

Authors:  Etsuko Mizutamari; Tomoko Honda; Takashi Ohba; Hidetaka Katabuchi
Journal:  Case Rep Obstet Gynecol       Date:  2014-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.